Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
“Since its foundation in 1999, the Copenhagen-based company has been developing antibody-based therapies to treat cancer. Now, it is Europe’s perhaps most fiercely independent biotech, though word on the street is that J&J is considering a buyout after the success of Darzalex”, European Biotech editor, Evelyn Warner, from Berlin based, Labiotech.eu, writes, motivating why Genmab belongs on the list.
Read full Labiotech ranking list here.
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Click here to read more about us!“Since its foundation in 1999, the Copenhagen-based company has been developing antibody-based therapies to treat cancer. Now, it is Europe’s perhaps most fiercely independent biotech, though word on the street is that J&J is considering a buyout after the success of Darzalex”, European Biotech editor, Evelyn Warner, from Berlin based, Labiotech.eu, writes, motivating why Genmab belongs on the list.
Read full Labiotech ranking list here.
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Click here to read more about us!
